Slated to open in 2023, Heathcock Hall will feature state-of-the-art research labs, classroom space, undergraduate labs, and collaborative spaces designed to help faculty and student entrepreneurs commercialize their innovations. The building will be named in honor of former chemistry dean Clayton Heathcock, in whose lab Rosen worked toward the doctoral degree he earned in 1985.
Longtime supporters of the college, the Rosens previously gave $1 million to the university to jump-start the project, supported a named lectureship in Heathcock's honor, and have given regularly to the college's annual fund. The co-founder and CEO of Arcus Biosciences, Rosen also worked at Abbott Laboratories and Pfizer and helped establish Flexus Biosciences, which was acquired by Bristol-Myers Squibb in 2015.
"I was blown away and quite conflicted about the whole idea of naming a building in my honor. I did nothing to deserve that," said Heathcock, who retired in 2004. "But we have all had teachers who changed the direction of our lives. I am grateful to Terry, who was a real standout in my lab in the 1980s."
"Berkeley's curriculum is very research-focused, and it became obvious to me when I arrived as a graduate student that not only were the research and specific project that Clayton proposed to me very exciting, but Clayton's way of interacting with his students, and his total passion for the science and engagement, were awesome," said Rosen. "It was a very special time for me, and I think a very important time for the Heathcock group, as well."